Create Your First Project

Start adding your projects to your portfolio. Click on "Manage Projects" to get started

MCL Immunoassay Platform

Maxwell Sensors, Inc., a leading biomedical research and development company that is committed to “MAXimizing WELLness” through the development of advanced bio-molecular testing systems, turned to Nectar to create a miniaturized, self-contained, microfluidic cartridge-based system that can quickly, accurately, and simultaneously identify all three cardiac markers.

Detecting Signs of Impending Heart Attack Before it Happens

When someone is at risk of an impending heart attack, or is in the midst of one, there are elevated levels of cardiac markers in his or her blood that can predict it. Fast detection of these cardiac markers by physicians in a variety of health care settings not only prevents heart attacks through initiation of treatment, but also facilitates treatment of patients in the throes of a cardiac event.

.pro-gallery-wix-wrapper {display: block !important;} .pro-gallery-wix-wrapper .gallery-item-container {opacity: 1 !important; display: block !important;}